Showing results (61-70 of 269) with videos related to
Sort By:
Pageof 27
Journal of Contemporary Brachytherapy|March 20, 2020
A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trialCarl Salembier, Ann Henry, Bradley R Pieters, et al.The Lancet. Oncology|September 5, 2014
Guidance on the management of diarrhoea during cancer chemotherapyJervoise Andreyev, Paul Ross, Clare Donnellan, et al.World Journal of Urology|January 20, 2024
Radiotherapy in metastatic bladder cancerSophie Ashley, Ananya Choudhury, Peter Hoskin, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
GEC-ESTRO ACROP prostate brachytherapy guidelinesAnn Henry, Bradley R Pieters, Frank André Siebert, et al.Radiation Oncology (London, England)|September 13, 2022
Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trialsKei Ito, Tetsuo Saito, Naoki Nakamura, et al.European Urology Open Science|September 4, 2023
Defining Oligometastatic Bladder Cancer: A Systematic ReviewAristotelis Bamias, Arnulf Stenzl, Flora Zagouri, et al.Expert Review of Anticancer Therapy|May 18, 2010
Radiotherapy for metastatic bone disease: current standards and future prospectusStephen Lutz, Simon S Lo, Edward Chow, et al.Physics and Imaging in Radiation Oncology|October 9, 2024
A review of whole gland prostate brachytherapy with focal dose escalation to intra-prostatic lesions: Clinical efficacy and technical aspectsJoel Poder, Peter Hoskin, Hayley Reynolds, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Limitations and future directions in identifying risk factors for radiotherapy related pelvic insufficiency fractures in gynecological cancers: A scoping reviewArtemis Bouzaki, Peter Hoskin, Claire E Higham, et al.International Journal of Radiation Oncology, Biology, Physics|February 6, 2008
A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancerCarie Corner, Ana Maria Rojas, Linda Bryant, et al.Pageof 27